Matthew Hamilton Rosenberg’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
PCA
MSV
BTCPP
VFA
CAM
EB
AIM
FFA
QPBE
Matthew Hamilton Rosenberg's LLY Position: Q3 2026 in Review
Matthew Hamilton Rosenberg increased its Eli Lilly (LLY) stake by 2.1% in Q3 2026, buying an estimated $18.9K and bringing the position to 764 shares worth $884K. The position accounts for 0.16% of the portfolio, ranked #68.
Matthew Hamilton Rosenberg first reported a position in LLY in Q1 2020 and has held it in 27 quarters since. The position peaked at $897K in Q2 2026. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Matthew Hamilton Rosenberg held 764 shares of Eli Lilly worth $884K as of Q3 2026.
- Matthew Hamilton Rosenberg bought 16 Eli Lilly shares in Q3 2026, an estimated $18.9K.
- Eli Lilly made up 0.16% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #68 holding.
- Matthew Hamilton Rosenberg first reported a position in Eli Lilly in Q1 2020 and has held it in 27 quarters since.
- Matthew Hamilton Rosenberg's Eli Lilly position peaked at $897K in Q2 2026.
- 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.